Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/1820 : 52Business WireProficient Auto Logistics Reports First Quarter 2024 Financial ResultsNASDAQ:PALProficient Auto Logistics Inc
2024/06/1820 : 51Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:SIXSix Flags Entertainment Corporation
2024/06/1820 : 49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:KLTRKaltura Inc
2024/06/1820 : 48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ISRIsoRay Inc
2024/06/1820 : 45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:ISRIsoRay Inc
2024/06/1820 : 45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSHATaysha Gene Therapies Inc
2024/06/1820 : 45Business WireAPCU/Center Parc Credit Union Selects Cotribute’s Digital Platform to Streamline Account Opening Process for Business Members
2024/06/1820 : 45GlobeNewswire Inc.Multitude SE - Managers' Transactions - JokelaXE:FRUMultitude SE
2024/06/1820 : 45GlobeNewswire Inc.Multitude SE - Managers' Transactions - JokelaTG:FRUMultitude SE
2024/06/1820 : 45PR Newswire (US)Incumbent Tesla is the Only Domestic Automaker in Cars.com's 2024 American-Made Index Top 10NYSE:CARSCars com Inc
2024/06/1820 : 45PR Newswire (US)Hershey Updates Science-Based Targets as It Advances Efforts to Reduce Greenhouse Gas EmissionsNYSE:HSYHershey Company
2024/06/1820 : 45PR Newswire (Canada)AtkinsRéalis choisie pour réaliser un nouveau cadre de services publics pour l'Angleterre, le Pays de Galles et l'Irlande du NordTSX:ATRLAtkinsRealis Group Inc
2024/06/1820 : 45PR Newswire (Canada)AtkinsRéalis appointed to deliver new utilities framework for England, Wales and Northern IrelandTSX:ATRLAtkinsRealis Group Inc
2024/06/1820 : 44Edgar (US Regulatory)Form 8-K - Current reportNYSE:VREVeris Residential Inc
2024/06/1820 : 44Edgar (US Regulatory)Form 8-K - Current reportNYSE:SIXSix Flags Entertainment Corporation
2024/06/1820 : 44GlobeNewswire Inc.Comstock Shareholder UpdateAMEX:LODEComstock Inc
2024/06/1820 : 44PR Newswire (US)Capital Rx Appoints Antonio Garcia Cueto as Chief Financial Officer
2024/06/1820 : 43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:IPHYFInnate Pharma (PK)
2024/06/1820 : 40Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNYSE:FUNCedar Fair LP
2024/06/1820 : 40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:SPHIFSuper Hi International Holdings Ltd (PK)
2024/06/1820 : 40PR Newswire (US)InteliChart Rated Top Patient Engagement Platform for Second Consecutive Year by Black Book Research
2024/06/1820 : 39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CGNTCognyte Software Ltd
2024/06/1820 : 39PR Newswire (US)Comviva introduces CNPaaS for advanced monetization with Network APIs
2024/06/1820 : 38Edgar (US Regulatory)Form 8-K - Current reportNYSE:FUNCedar Fair LP
2024/06/1820 : 37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITCIIntra Cellular Therapies Inc
2024/06/1820 : 37GlobeNewswire Inc.La filiale de DeFi Technologies, Valour Inc., présente le premier et unique ETP à rendement en bitcoin (BTC) en collaboration avec la Core Foundation, aux investisseurs allemands sur la Bourse de Francfort offrant une exposition au bitcoin avec un rendemTG:R9BDeFi Technologies Inc
2024/06/1820 : 37GlobeNewswire Inc.Valour Inc. eine Tochtergesellschaft von DeFi Technologies, führt in Zusammenarbeit mit der Core Foundation das weltweit erste und einzige renditeträchtige Bitcoin (BTC) ETP ein – Engagement in Bitcoin an der Börse Frankfurt für deutsche Anleger mitTG:R9BDeFi Technologies Inc
2024/06/1820 : 37PR Newswire (US)Comviva introduces CNPaaS for advanced monetization with Network APIs
2024/06/1820 : 37PR Newswire (Canada)Comviva introduces CNPaaS for advanced monetization with Network APIs
2024/06/1820 : 35GlobeNewswire Inc.Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)TSXV:ARCHArch Biopartners Inc